2013 CMV Diagnostics Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country


December 24, 2012
231 Pages - SKU: VPG4983934
License type:
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
5/8/2013 | published by: Kalorama Information
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis,  |  read more...
$4,500.00
Analysis of the Global In Vitro Diagnostics Market
5/2/2013 | published by: Frost & Sullivan
Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical industry. This research deliverable leverages primary research, secondary sources, and Frost & Sullivan’s  |  read more...
$6,000.00
Hospital Construction in the US - Industry Market Research Report
5/3/2013 | published by: IBISWorld
Hospital Construction Over the next five years, the Hospital Construction industry is expected to enter into a recovery period. The implementation of the Patient Protection and Affordable Care Act will result in more than 32 million  |  read more...
$1,020.00
SMBG Market in India 2013
5/2/2013 | published by: Netscribes (India) Pvt. Ltd.
SMBG equipments has witnessed strong growth over the last few years on account of large number of diabetics and increasing awareness towards SMBG. People are also becoming aware of the harmful effects of diabetes.
read more...
$850.00
Switzerland Pharmaceuticals and Healthcare Report Q2 2013
5/8/2013 | published by: Business Monitor International
BMI View: While the patent cliff and the consequent availability of generic drugs, as well as price cuts ongeneric medicines and their increasing affordability, will work towards increasing the consumption ofgeneric medicines in Switzerland, BMI  |  read more...
$1,175.00
Australia Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
BMI View: As a developed market, Australia represents opportunities for risk averse pharmaceuticalinvestors, given its ageing and generally affluent population. Importantly, the government is implementingcost-cutting measures to cope with escalating healthcare costs, therefore generic drugmakers  |  read more...
$1,175.00
Cameroon Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
BMI View: Despite the strong growth potential of its pharmaceutical market, we believe Cameroon isunlikely to be of significant interest to multinational pharmaceutical firms. The country's shortcomingsinclude poor public health provision and rampant corruption. Consequently  |  read more...
$1,175.00
Namibia Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
BMI View: We expect Namibia's negative pharmaceutical trade balance to widen as demand for medicinescontinues to be met by imports, and poor local manufacturing sees exports contract in the medium term.Headline Expenditure Forecasts Pharmaceuticals: NAD2.20bn  |  read more...
$1,175.00
Nigeria Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
Executive Summary BMI View: Boosting bilateral co-operation between Nigerian buyers and Indian drugmakers will directlyobstruct the Nigerian government's goal to increase self-sufficiency in medicines production. We do notbelieve implementing a selected import ban on pharmaceuticals should  |  read more...
$1,175.00
Russian Pharma Industry In Details
5/9/2013 | published by: Euroresearch & Consulting
Russian Pharma Industry In Details Purpose of this report was to analyze Russian of pharma. Please pay attention: Benefits of buying the report: The report included large volume  |  read more...
$3,750.00